Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-07-21Clinical Trial Update: Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b [Phase 2]
Phase 2 trial evaluating atorvastatin 40 mg in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b; study status…
-
CLINICAL_TRIALS trial_result · 2009-06-23Clinical Trial Update: EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis [NA]
Completed clinical trial studying early interferon beta-1a combined with atorvastatin for isolated clinical syndrome suggestive of multiple …
-
CLINICAL_TRIALS trial_result · 2009-06-10Clinical Trial Update: Immunogenicity and Safety Study of Serum-Free Avonex [Phase 2]
A Phase 2 trial assessing the immunogenicity and safety of Serum-Free Avonex in multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2009-06-08Clinical Trial Update: Open-Label Safety Extension Study of Avonex [Phase 4]
Open-label safety extension study of Avonex (interferon beta-1a) for multiple sclerosis has completed its Phase 4 safety extension.
-
CLINICAL_TRIALS trial_result · 2009-06-08Clinical Trial Update: Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe [Phase 3]
A Phase 3 clinical trial update evaluating patient satisfaction with a single-use autoinjector for delivering Avonex (interferon beta-1a) in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-06-04Clinical Trial Update: A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers [Phase 1]
Phase 1 bioequivalence study evaluating serum-free Avonex versus Avonex-containing serum in healthy volunteers, sponsored by Biogen.
-
CLINICAL_TRIALS trial_result · 2009-06-04Clinical Trial Update: Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers [Phase 4]
A Phase 4 pharmacodynamic study update evaluating the therapeutic response and immunomodulatory effects of Avonex in multiple sclerosis pati…
-
CLINICAL_TRIALS trial_result · 2009-05-04Clinical Trial Update: Motor Imagery Practice in Neurological Rehabilitation [Phase 2]
A Phase 2 trial evaluating motor imagery practice in neurological rehabilitation has completed, with stroke, brain injury, and multiple scle…
-
CLINICAL_TRIALS trial_result · 2009-03-11Clinical Trial Update: Differential Immune Effects of Natalizumab
This completed trial update reports differential immune effects observed with Natalizumab in relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2009-02-19Clinical Trial Update: One Year Extension Study To Protocol C2/5/TZ:MS-05 [Phase 1, Phase 2]
One-year extension study to a Phase 1/2 trial (Protocol C2/5/TZ:MS-05) in spasticity associated with multiple sclerosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated nighttime dosing of sublingual tizanidine (12 mg) for spasticity in patients with multiple sclerosis; t…
-
CLINICAL_TRIALS trial_result · 2008-12-19Clinical Trial Update: BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients [Phase 3]
Phase 3 trial update reporting outcomes of a new dose of Betaferon/Betaseron (interferon beta-1b) in relapsing-remitting multiple sclerosis.…
-
CLINICAL_TRIALS trial_result · 2008-11-04Clinical Trial Update: Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis [Phase 2]
Phase 2 trial of AV650 for spasticity in people with multiple sclerosis was terminated; the update discusses safety and preliminary effectiv…
-
CLINICAL_TRIALS trial_result · 2008-09-09Clinical Trial Update: Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis [Phase 3]
Phase III randomized, double-blind, placebo-controlled trial evaluating intravenous immunoglobulin for multiple sclerosis has completed. The…
-
CLINICAL_TRIALS trial_result · 2008-08-12Clinical Trial Update: Multiple Sclerosis and Heavy Progressive Resistance Training [NA]
A clinical trial studying heavy progressive resistance training for individuals with Multiple Sclerosis has completed. The record lists the …
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating subcutaneous daclizumab in patients with active, relapsing f…
-
CLINICAL_TRIALS trial_result · 2008-06-11Clinical Trial Update: Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS) [Phase 1]
Phase 1 trial of constraint-induced movement therapy for progressive multiple sclerosis has completed. The study investigates CI therapy to …
-
CLINICAL_TRIALS trial_result · 2008-06-04Clinical Trial Update: Auditory Function in Patients With and Without Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial evaluating auditory function in patients with and without Multiple Sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-28Clinical Trial Update: A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update for C105 assessing cognitive dysfunction in persons with multiple sclerosis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-07Clinical Trial Update: Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis [Phase 1]
A Phase 1 trial assessing immunotherapy BHT-3009 alone or combined with atorvastatin in patients with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-28Clinical Trial Update: Safety Trial of High Dose Oral Vitamin D3 With Calcium in Multiple Sclerosis [Phase 1, Phase 2]
This document reports the completion of a Phase 1/2 safety trial of high-dose oral vitamin D3 with calcium in people with Multiple Sclerosis…
-
CLINICAL_TRIALS trial_result · 2008-03-21Clinical Trial Update: Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS) [Phase 2]
A Phase 2 clinical trial evaluating NBI-5788, an altered peptide ligand, in relapsing multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-05Clinical Trial Update: EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis [Phase 4]
Phase 4 trial of early interferon beta-1a in combination with simvastatin for Clinically Isolated Syndrome suggestive of Multiple Sclerosis …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS) [Phase 2]
The National Institute of Neurological Disorders and Stroke completed a Phase 2 trial evaluating CGP77116 in multiple sclerosis, reporting o…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Rolipram to Treat Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update for Rolipram in multiple sclerosis; the study has completed.